Cori DeSanto1, Kristin D'Aco2, Gabriel C Araujo3, Nora Shannon4, Hilary Vernon5, April Rahrig6, Kristin G Monaghan7, Zhiyv Niu8, Patrik Vitazka7, Jonathan Dodd3, Sha Tang9, Linda Manwaring1, Arelis Martir-Negron10, Rhonda E Schnur7, Jane Juusola7, Audrey Schroeder2, Vivian Pan6, Katherine L Helbig9, Bethany Friedman7, Marwan Shinawi1. 1. Division of Genetics and Genomic Medicine, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA. 2. Division of Genetics, Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. 3. Department of Psychology, St Louis Children's Hospital, St Louis, Missouri, USA. 4. Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK. 5. Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA McKusick Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA. 6. Department of Pediatrics, Advocate Children's Hospital, Park Ridge, Illinois, USA. 7. GeneDx, Gaithersburg, Maryland, USA. 8. Department of Molecular and Human Genetics, Whole Genome Laboratory and Medical Genetics Laboratories, Baylor College of Medicine, Houston, Texas, USA. 9. Division of Clinical Genomics, Ambry Genetics, Aliso Viejo, California, USA. 10. Department of Pediatrics, Advocate Children's Hospital, Park Ridge, Illinois, USA Division of Clinical Genetics & Metabolic Disorders, Palm Beach Gardens Outpatient Center, Nicklaus Children's Hospital, Miami, Florida, USA.
Abstract
BACKGROUND: Rare de novo mutations have been implicated as a significant cause of idiopathic intellectual disability. Large deletions encompassing 10p11.23 have been implicated in developmental delay, behavioural abnormalities and dysmorphic features, but the genotype-phenotype correlation was not delineated. Mutations in WAC have been recently reported in large screening cohorts of patients with intellectual disability or autism, but no full phenotypic characterisation was described. METHODS: Clinical and molecular characterisation of six patients with loss-of-function WAC mutations identified by whole exome sequencing was performed. Clinical data were obtained by retrospective chart review, parental interviews, direct patient interaction and formal neuropsychological evaluation. RESULTS: Five heterozygous de novo WAC mutations were identified in six patients. Three of the mutations were nonsense, and two were frameshift; all are predicted to cause loss of function either through nonsense-mediated mRNA decay or protein truncation. Clinical findings included developmental delay (6/6), hypotonia (6/6), behavioural problems (5/6), eye abnormalities (5/6), constipation (5/6), feeding difficulties (4/6), seizures (2/6) and sleep problems (2/6). All patients exhibited common dysmorphic features, including broad/prominent forehead, synophrys and/or bushy eyebrows, depressed nasal bridge and bulbous nasal tip. Posteriorly rotated ears, hirsutism, deep-set eyes, thin upper lip, inverted nipples, hearing loss and branchial cleft anomalies were also noted. CONCLUSIONS: Our case series show that loss-of-function mutations in WAC cause a recognisable genetic syndrome characterised by a neurocognitive phenotype and facial dysmorphism. Our data highly suggest that WAC haploinsufficiency is responsible for most of the phenotypic features associated with deletions encompassing 10p11.23. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND: Rare de novo mutations have been implicated as a significant cause of idiopathic intellectual disability. Large deletions encompassing 10p11.23 have been implicated in developmental delay, behavioural abnormalities and dysmorphic features, but the genotype-phenotype correlation was not delineated. Mutations in WAC have been recently reported in large screening cohorts of patients with intellectual disability or autism, but no full phenotypic characterisation was described. METHODS: Clinical and molecular characterisation of six patients with loss-of-function WAC mutations identified by whole exome sequencing was performed. Clinical data were obtained by retrospective chart review, parental interviews, direct patient interaction and formal neuropsychological evaluation. RESULTS: Five heterozygous de novo WAC mutations were identified in six patients. Three of the mutations were nonsense, and two were frameshift; all are predicted to cause loss of function either through nonsense-mediated mRNA decay or protein truncation. Clinical findings included developmental delay (6/6), hypotonia (6/6), behavioural problems (5/6), eye abnormalities (5/6), constipation (5/6), feeding difficulties (4/6), seizures (2/6) and sleep problems (2/6). All patients exhibited common dysmorphic features, including broad/prominent forehead, synophrys and/or bushy eyebrows, depressed nasal bridge and bulbous nasal tip. Posteriorly rotated ears, hirsutism, deep-set eyes, thin upper lip, inverted nipples, hearing loss and branchial cleft anomalies were also noted. CONCLUSIONS: Our case series show that loss-of-function mutations in WAC cause a recognisable genetic syndrome characterised by a neurocognitive phenotype and facial dysmorphism. Our data highly suggest that WAChaploinsufficiency is responsible for most of the phenotypic features associated with deletions encompassing 10p11.23. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Sandra Jansen; Alexander Hoischen; Bradley P Coe; Gemma L Carvill; Hilde Van Esch; Daniëlle G M Bosch; Ulla A Andersen; Carl Baker; Marijke Bauters; Raphael A Bernier; Bregje W van Bon; Hedi L Claahsen-van der Grinten; Jozef Gecz; Christian Gilissen; Lucia Grillo; Anna Hackett; Tjitske Kleefstra; David Koolen; Malin Kvarnung; Martin J Larsen; Carlo Marcelis; Fiona McKenzie; Marie-Lorraine Monin; Caroline Nava; Janneke H Schuurs-Hoeijmakers; Rolph Pfundt; Marloes Steehouwer; Servi J C Stevens; Connie T Stumpel; Fleur Vansenne; Mirella Vinci; Maartje van de Vorst; Petra de Vries; Kali Witherspoon; Joris A Veltman; Han G Brunner; Heather C Mefford; Corrado Romano; Lisenka E L M Vissers; Evan E Eichler; Bert B A de Vries Journal: Eur J Hum Genet Date: 2017-12-05 Impact factor: 4.246
Authors: Gregory Costain; Rebekah Jobling; Susan Walker; Miriam S Reuter; Meaghan Snell; Sarah Bowdin; Ronald D Cohn; Lucie Dupuis; Stacy Hewson; Saadet Mercimek-Andrews; Cheryl Shuman; Neal Sondheimer; Rosanna Weksberg; Grace Yoon; M Stephen Meyn; Dimitri J Stavropoulos; Stephen W Scherer; Roberto Mendoza-Londono; Christian R Marshall Journal: Eur J Hum Genet Date: 2018-02-16 Impact factor: 4.246
Authors: Claire Redin; Harrison Brand; Ryan L Collins; Tammy Kammin; Elyse Mitchell; Jennelle C Hodge; Carrie Hanscom; Vamsee Pillalamarri; Catarina M Seabra; Mary-Alice Abbott; Omar A Abdul-Rahman; Erika Aberg; Rhett Adley; Sofia L Alcaraz-Estrada; Fowzan S Alkuraya; Yu An; Mary-Anne Anderson; Caroline Antolik; Kwame Anyane-Yeboa; Joan F Atkin; Tina Bartell; Jonathan A Bernstein; Elizabeth Beyer; Ian Blumenthal; Ernie M H F Bongers; Eva H Brilstra; Chester W Brown; Hennie T Brüggenwirth; Bert Callewaert; Colby Chiang; Ken Corning; Helen Cox; Edwin Cuppen; Benjamin B Currall; Tom Cushing; Dezso David; Matthew A Deardorff; Annelies Dheedene; Marc D'Hooghe; Bert B A de Vries; Dawn L Earl; Heather L Ferguson; Heather Fisher; David R FitzPatrick; Pamela Gerrol; Daniela Giachino; Joseph T Glessner; Troy Gliem; Margo Grady; Brett H Graham; Cristin Griffis; Karen W Gripp; Andrea L Gropman; Andrea Hanson-Kahn; David J Harris; Mark A Hayden; Rosamund Hill; Ron Hochstenbach; Jodi D Hoffman; Robert J Hopkin; Monika W Hubshman; A Micheil Innes; Mira Irons; Melita Irving; Jessie C Jacobsen; Sandra Janssens; Tamison Jewett; John P Johnson; Marjolijn C Jongmans; Stephen G Kahler; David A Koolen; Jerome Korzelius; Peter M Kroisel; Yves Lacassie; William Lawless; Emmanuelle Lemyre; Kathleen Leppig; Alex V Levin; Haibo Li; Hong Li; Eric C Liao; Cynthia Lim; Edward J Lose; Diane Lucente; Michael J Macera; Poornima Manavalan; Giorgia Mandrile; Carlo L Marcelis; Lauren Margolin; Tamara Mason; Diane Masser-Frye; Michael W McClellan; Cinthya J Zepeda Mendoza; Björn Menten; Sjors Middelkamp; Liya R Mikami; Emily Moe; Shehla Mohammed; Tarja Mononen; Megan E Mortenson; Graciela Moya; Aggie W Nieuwint; Zehra Ordulu; Sandhya Parkash; Susan P Pauker; Shahrin Pereira; Danielle Perrin; Katy Phelan; Raul E Piña Aguilar; Pino J Poddighe; Giulia Pregno; Salmo Raskin; Linda Reis; William Rhead; Debra Rita; Ivo Renkens; Filip Roelens; Jayla Ruliera; Patrick Rump; Samantha L P Schilit; Ranad Shaheen; Rebecca Sparkes; Erica Spiegel; Blair Stevens; Matthew R Stone; Julia Tagoe; Joseph V Thakuria; Bregje W van Bon; Jiddeke van de Kamp; Ineke van Der Burgt; Ton van Essen; Conny M van Ravenswaaij-Arts; Markus J van Roosmalen; Sarah Vergult; Catharina M L Volker-Touw; Dorothy P Warburton; Matthew J Waterman; Susan Wiley; Anna Wilson; Maria de la Concepcion A Yerena-de Vega; Roberto T Zori; Brynn Levy; Han G Brunner; Nicole de Leeuw; Wigard P Kloosterman; Erik C Thorland; Cynthia C Morton; James F Gusella; Michael E Talkowski Journal: Nat Genet Date: 2016-11-14 Impact factor: 38.330
Authors: Enrique Audain; Anna Wilsdon; Jeroen Breckpot; Jose M G Izarzugaza; Tomas W Fitzgerald; Anne-Karin Kahlert; Alejandro Sifrim; Florian Wünnemann; Yasset Perez-Riverol; Hashim Abdul-Khaliq; Mads Bak; Anne S Bassett; D Woodrow Benson; Felix Berger; Ingo Daehnert; Koenraad Devriendt; Sven Dittrich; Piers Ef Daubeney; Vidu Garg; Karl Hackmann; Kirstin Hoff; Philipp Hofmann; Gregor Dombrowsky; Thomas Pickardt; Ulrike Bauer; Bernard D Keavney; Sabine Klaassen; Hans-Heiner Kramer; Christian R Marshall; Dianna M Milewicz; Scott Lemaire; Joseph S Coselli; Michael E Mitchell; Aoy Tomita-Mitchell; Siddharth K Prakash; Karl Stamm; Alexandre F R Stewart; Candice K Silversides; Reiner Siebert; Brigitte Stiller; Jill A Rosenfeld; Inga Vater; Alex V Postma; Almuth Caliebe; J David Brook; Gregor Andelfinger; Matthew E Hurles; Bernard Thienpont; Lars Allan Larsen; Marc-Phillip Hitz Journal: PLoS Genet Date: 2021-07-29 Impact factor: 6.020